ETH-LAD
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "ETH-LAD".

ETH-LAD
Systematic (IUPAC) name
(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9- hexahydroindolo-[4,3-fgquinoline-9-carboxamide
Identifiers
CAS number	?
ATC code	?
PubChem	?
Chemical data
Formula	C21H27N3O
Mol. mass	337.47 g/mol
Synonyms	ETH-LAD, 6-ethyl-6-nor-Lysergic acid diethylamide
Pharmacokinetic data
Bioavailability	?
Metabolism	hepatic
Half life	?
Excretion	renal
Therapeutic considerations
Pregnancy cat.	?
Legal status	Controlled in the US via the Federal Analog Act
Routes	Oral

ETH-LAD, 6-ethyl-6-nor-lysergic acid diethylamide is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. ETH-LAD is a hallucinogenic drug similar to LSD, and is slightly more potent than LSD itself with an active dose reported at between 40 and 150 micrograms. ETH-LAD has subtly different effects to LSD, described as less demanding.

ETH-LAD has been sold by some research chemical suppliers but might be considered illegal in some countries due to its structural similarity to LSD.

External links

ETH-LAD entry in TIHKAL

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.